Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2003
12/04/2003CA2485732A1 Generation and selection of protein library in silico
12/04/2003CA2485691A1 Treatment of renal carcinoma using antibodies against the egfr
12/04/2003CA2484000A1 Neutralizing human anti-igfr antibody
12/04/2003CA2483201A1 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
12/04/2003CA2482881A1 Diagnosis of hepatocellular carcinoma
12/04/2003CA2478833A1 Anti-.alpha.v.beta.6 antibodies
12/03/2003EP1367395A1 Diagnosis of neoplasms with the help of anti-gangliosid-antibodies
12/03/2003EP1367393A1 Methods for using the CD 163 pathway for modulating an immune response
12/03/2003EP1367123A1 Neurotonin and use thereof
12/03/2003EP1366769A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing extracellular matrix receptor-ligand interaction
12/03/2003EP1366455A2 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity
12/03/2003EP1366366A2 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
12/03/2003EP1366363A1 Methods for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes
12/03/2003EP1366174A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
12/03/2003EP1366173A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
12/03/2003EP1366169A2 Antigenic proteins of shrimp white spot syndrome virus and uses thereof
12/03/2003EP1366167A2 Biological organism for preparing pharmaceutical compositions for treating mammals
12/03/2003EP1366165A2 G-protein coupled receptors
12/03/2003EP1366162A2 Putative proteins and nucleic acids encoding same
12/03/2003EP1366161A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
12/03/2003EP1366157A2 Compositions and methods for the therapy and diagnosis of lung cancer
12/03/2003EP1366156A2 Osteolevin gene polymorphisms
12/03/2003EP1366152A2 G-protein coupled receptors
12/03/2003EP1366146A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
12/03/2003EP1366080A1 Natural antibodie active against hiv virus
12/03/2003EP1366079A2 Nuclear hormone receptor ligand binding domain
12/03/2003EP1366078A2 Ige receptor antagonists
12/03/2003EP1366077A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
12/03/2003EP1366076A2 Compounds and methods for modulating desmosomal cadherin-mediated functions
12/03/2003EP1366067A2 Expression technology for proteins containing a hybrid isotype antibody moiety
12/03/2003EP1365813A2 Ascorbic acid analogs for metalloradiopharmaceuticals
12/03/2003EP1365804A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
12/03/2003EP1365797A2 Methods and agents modulating upa/upar activity
12/03/2003EP1123301B1 Chelating agents for radioimmunotherapy
12/03/2003EP1115427B1 Time-staggered utilization of tumor cells in combination with intact antibodies for immunization
12/03/2003EP1064306B1 Nephrin gene and protein
12/03/2003EP0724644B1 Dna encoding 1,3-beta-d glucan synthase subunits
12/03/2003EP0687295B1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody
12/03/2003CN1460111A HIV peptides from conserved regions in GAGP 17 and 924 and their application in e.g. vaccines
12/03/2003CN1460025A Immunomodulatory human MHC class Ôàí antigen-binding polypeptides
12/03/2003CN1459634A Method of determining immunology
12/03/2003CN1459503A Jiulian agglutinin protein and its code sequence
12/03/2003CN1129796C Medicine box for detecting hepatitis virus C and use thereof
12/03/2003CN1129609C Flocculation clarification ultrafiltration concentration process of producing composite immunoreactive protein
12/02/2003US6657103 Human antibodies derived from immunized xenomice
12/02/2003US6657048 Individualized anti-cancer antibodies
12/02/2003US6657047 Nucleotide sequences coding polypeptide for use in the treatment of tumors, inflammation, psoriasis, rheumatoid arthritis, cardiovascular and vision disorders
12/02/2003US6656743 Human choline acetyltransferase
12/02/2003US6656717 Cyclic AMP phosphodiesterase isoforms and methods of use
12/02/2003US6656716 Polypeptide fragments of human PAK5 protein kinase
12/02/2003US6656713 Compounds and methods for modulating activation of NF-κB
12/02/2003US6656708 Splice variant; expression vectors
12/02/2003US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides
12/02/2003US6656705 Sciellin and uses thereof
12/02/2003US6656704 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
12/02/2003US6656698 12832, a novel human kinase-like molecule and uses thereof
12/02/2003US6656681 Polycystic kidney disease 12 gene and uses thereof
12/02/2003US6656679 Heat shock protein-based vaccines and immunotherapies
12/02/2003US6656475 Modulating growth of muscle or adipose tissue in eukaryotic organism using agent that affects myostatin signal transduction
12/02/2003US6656469 Treatment of nicotine dependence from tobacco products
12/02/2003US6656468 Such as botulinus antitoxin orally
12/02/2003US6656467 Genetic engineering; administering immunoglobulins
12/02/2003US6656465 Antibodies that mimic actions of neurotrophins
12/02/2003US6656461 Inhibiting apoptosis of lung cells
12/02/2003CA2172165C Human receptor h4-1bb
12/02/2003CA2046904C Cd4 specific recombinant antibody
11/2003
11/30/2003CA2388456A1 Macroaggregated albumin-polyethyleneimine (maa-pei) lung-targeted delivery of respiratory syncytial virus dna vaccines
11/27/2003WO2003098214A1 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
11/27/2003WO2003098190A2 Protein identification from protein product ion spectra
11/27/2003WO2003097875A1 Diagnosis of abnormal blood conditions based on polymorphisms in the glycoprotein vi gene
11/27/2003WO2003097871A2 Marker molecules associated with lung tumors
11/27/2003WO2003097837A1 Stress-responsive gene specific to root
11/27/2003WO2003097825A2 Novel phospholipases and uses thereof
11/27/2003WO2003097823A1 Regulation of human serine/threonine kinase
11/27/2003WO2003097821A1 Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide
11/27/2003WO2003097798A2 Carotene synthase gene and uses therefor
11/27/2003WO2003097796A2 T7 bacteriophage display of fabs
11/27/2003WO2003097698A1 Treatment of cancer by the use of anti fas antibody
11/27/2003WO2003097697A2 Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
11/27/2003WO2003097688A2 Muteins of placental growth factor type 1, preparation method and application thereof
11/27/2003WO2003097686A1 Novel protein, its dna and use thereof
11/27/2003WO2003097676A1 Polypeptide antigen inducing hiv neutralizing antibodies
11/27/2003WO2003097666A2 Use of gastrin releasing peptide (grp) and its receptor in cancer screening
11/27/2003WO2003097663A2 Immunogenic, monoclonal antibody comprising at least 2 different epitopes of a tumor-associated antigen
11/27/2003WO2003097660A1 Vascular endothelial growth factor 2
11/27/2003WO2003097105A1 Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent (s)
11/27/2003WO2003097097A1 Method of treating and/or preventing acute leukemia using medicinal composition for therapeutic use containing vla4 antagonist, and method of diagnosing prognosis of acute leukemia using vla4 as indication
11/27/2003WO2003097094A1 Method of prophylaxis of infection
11/27/2003WO2003097093A1 METHOD OF TREATING IMMUNE-MEDIATED DISEASES BY ADMINISTRATION OF IgM
11/27/2003WO2003097092A1 Use of a vaccine for active immunization against cancer
11/27/2003WO2003097091A2 Glucan-based vaccines
11/27/2003WO2003097082A2 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
11/27/2003WO2003096974A2 ORIENTIA TSUTSUGAMUSHI TRUNCATED RECOMBINANT OUTER MENBRANE PROTEIN (r47) AND (r56) VACCINES DIAGNOSTICS AND THERAPEUTICS FOR SCRUB TYPHUS AND HIV INFECTION
11/27/2003WO2003096966A2 Chimeric ige polypeptides and host cells
11/27/2003WO2003096877A2 Prevention and treatment of streptococcal and staphylococcal infection
11/27/2003WO2003096782A2 Process for preparing maytansinol
11/27/2003WO2003080669A3 Anti-hpv-16 e7 antibodies and their use
11/27/2003WO2003076469A3 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
11/27/2003WO2003075841A3 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
11/27/2003WO2003073981A3 Novel of cytokine inhibitors
1 ... 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 ... 1494